9 BEAUTIFUL graphs on the stock market!

Tiger_Chart
11-25

Here are 9 BEAUTIFUL graphs on the stock market!

1/ $NEBIUS(NBIS)$ Forward Revenues

$21M ➡️ $5.8B

277x in 4 years!

Simply INCREDIBLE!

2/ $Alphabet(GOOGL)$ Cloud EBIT

-$5.6B ➡️ $10.7B

In how many years will it reach $100B?

3/ $IREN Ltd(IREN)$ Forward Revenues

$8M ➡️ $3.9B

488x in 7 years!

UNBELIEVABLE!

4/ $Uber(UBER)$ FCF

-$3.4B ➡️ $8.5B in 3 years

5/ $Grab Holdings(GRAB)$ Net Income

-$1.9B ➡️ $122M

The graph will look the same as $UBER in no time.

6/ $Oscar Health, Inc.(OSCR)$ Revenues

$455M ➡️ $11.1B

24x in 5 years!

8/ $Nu Holdings Ltd.(NU)$

📈 ARPU: +306%

📉 Cost per ARPU: -18%

Operating leverage at scale.

9/ $Sea Ltd(SE)$ Fintech Business

$40M ➡️ $3.4B

Unbelievable growth in just 5 years!

10/ $Eli Lilly(LLY)$ Mounjaro Fat Loss Drug

$0 ➡️ $20B in 3 years

For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD 5000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.

Click to access the activity

Other helpful links:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment